Chapter 11. Thromboxane Synthase Inhibitors and Receptor Antagonists
- 1 January 1990
- book chapter
- Published by Elsevier
- Vol. 25, 99-108
- https://doi.org/10.1016/s0065-7743(08)61587-0
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Angioscopic study of the antithrombotic effect of a new selective thromboxane A2 synthetase inhibitor, CV-4151, on experimental arterial thrombiAmerican Heart Journal, 1989
- Phase I Study of Y‐20811, a New Long‐Acting Thromboxane Synthetase Inhibitor by Intravenous AdministrationThe Journal of Clinical Pharmacology, 1989
- Phase I Study of Y-20811, a New Long-Acting Thromboxane Synthetase Inhibitor by Oral AdministrationThe Journal of Clinical Pharmacology, 1989
- The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction modelsAmerican Heart Journal, 1989
- Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in catsAmerican Heart Journal, 1989
- Thromboxane A2 receptor antagonists. I. Synthesis and pharmacological activity of 7-oxabicyclo-(2.2.1)heptane derivatives with the benzenesulfonylamino group.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Thromboxane A2 receptor antagonists. II. Synthesis and pharmacological activity of 6,6-dimethylbicyclo(3.1.1)heptane derivatives with the benzenesulfonylamino group.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Thromboxane A2 receptor antagonists. III. Synthesis and pharmacological activity of 6,6-dimethylbicyclo(3.1.1.)heptane derivatives with a substituted sulfonylamino group at C-2.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Thromboxane Synthase Activity and Platelet Function After Furegrelate Administration in ManThe Journal of Clinical Pharmacology, 1989
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983